Trade Names:
Synonyms:
Status: Approved (2012)
Entry Type: Small molecule
Molecule Category: UNKNOWN
ATC: A07XA06
UNII: PY79D6C8RX

Pharmacology

Action Mechanism of Action Reference
BLOCKER Anoctamin-1 blocker
Primary Target
CaCC
CFTR

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Irritable Bowel Syndrome 2 D043183 ClinicalTrials
Breast Neoplasms 2 D001943 ClinicalTrials

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
30.0
Gastrointestinal disorders
25.0
Nervous system disorders
10.0
Cardiac disorders
5.0
Injury, poisoning and procedural complications
5.0
Metabolism and nutrition disorders
5.0
Psychiatric disorders
5.0
Renal and urinary disorders
5.0
Skin and subcutaneous tissue disorders
5.0
Vascular disorders
5.0

Cross References

Resources Reference
CAS NUMBER 148465-45-6
ChEMBL CHEMBL2108184
FDA SRS PY79D6C8RX
Guide to Pharmacology 7453